Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
30.12
-0.69 (-2.24%)
Apr 9, 2026, 1:06 PM EDT - Market open

Nanobiotix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,4561,119136269128282
Market Cap Growth
744.45%724.71%-49.54%110.40%-54.65%-50.38%
Enterprise Value
1,5061,164131.83236.14135.61229.54
Last Close Price
30.1223.132.877.283.678.10
PE Ratio
--39.42-1.92-6.10-2.09-5.27
PS Ratio
38.0529.28-18.146.7224.9693.68
PB Ratio
--11.29-1.99-132.04-4.419.26
P/TBV Ratio
-17.05-13.09-2.07-145.97-4.7310.50
P/FCF Ratio
--28.10-6.40-19.01-3.20-8.24
P/OCF Ratio
--28.55-6.67-19.51-3.21-8.30
EV/Sales Ratio
39.3530.45-17.625.9026.4776.26
EV/EBITDA Ratio
--106.45-1.90-8.45-2.80-3.96
EV/EBIT Ratio
--91.74-1.85-7.98-2.71-3.84
EV/FCF Ratio
--29.22-6.21-16.68-3.40-6.71
Debt / Equity Ratio
-1.08-1.08-0.70-24.71-1.801.41
Debt / EBITDA Ratio
-11.18-10.22-0.76-2.00-1.18-0.90
Debt / FCF Ratio
-2.81-2.81-2.50-3.95-1.43-1.53
Net Debt / Equity Ratio
-0.50-0.50-0.0213.41-0.44-1.41
Net Debt / EBITDA Ratio
-4.99-4.57-0.020.98-0.260.74
Net Debt / FCF Ratio
-1.25-1.25-0.061.93-0.321.26
Asset Turnover
0.480.48-0.090.470.060.02
Quick Ratio
0.950.950.891.531.092.28
Current Ratio
1.091.091.041.751.382.53
Return on Equity (ROE)
31.91%31.91%201.73%274.85%44738.82%-96.66%
Return on Assets (ROA)
-16.01%-16.01%-84.92%-34.96%-57.83%-44.60%
Return on Invested Capital (ROIC)
-612.30%-612.30%6925.53%-587.94%-464.18%-549.50%
Return on Capital Employed (ROCE)
-115.48%-115.48%-260.51%-81.32%-107.66%-58.45%
Earnings Yield
-1.93%-2.54%-52.17%-16.39%-47.95%-18.96%
FCF Yield
-2.73%-3.56%-15.64%-5.26%-31.20%-12.14%
Buyback Yield / Dilution
-1.28%-1.17%-27.99%-5.96%-0.34%-42.43%
Total Shareholder Return
-1.28%-1.17%-27.99%-5.96%-0.34%-42.43%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q